| Literature DB >> 27595112 |
Jennifer C Harvey1, Bruno T Roseguini2, Benjamin M Goerger1, Elizabeth A Fallon1, Brett J Wong1.
Abstract
We tested the hypothesis that a high fat meal (HFM) would impair cutaneous vasodilation, while thermotherapy (TT) would reverse the detrimental effects. Eight participants were instrumented with skin heaters and laser-Doppler (LD) probes and tested in three trials: control, HFM, and HFM + TT. Participants wore a water-perfused suit perfused with 33°C (control and HFM) or 50°C (HFM + TT) water. Participants consumed 1 g fat/kg body weight. Blood samples were taken at baseline and two hours post-HFM. Blood pressure was measured every 5-10 minutes. Microvascular function was assessed via skin local heating from 33°C to 39°C two hours after HFM. Cutaneous vascular conductance (CVC) was calculated and normalized to maximal vasodilation (%CVCmax). HFM had no effect on initial peak (48 ± 4 %CVCmax) compared to control (49 ± 4 %CVCmax) but attenuated the plateau (51 ± 4 %CVCmax) compared to control (63 ± 4 %CVCmax, P < 0.001). Initial peak was augmented in HFM + TT (66 ± 4 %CVCmax) compared to control and HFM (P < 0.05), while plateau (73 ± 3 % CVCmax) was augmented only compared to the HFM trial (P < 0.001). These data suggest that HFM negatively affects cutaneous vasodilation but can be minimized by TT.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27595112 PMCID: PMC4993934 DOI: 10.1155/2016/1902325
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Figure 1Schematic illustration of the experimental protocol. (a) HFM (thermoneutral) protocol and (b) HFM-TT protocol. Arrows indicate time points where finger stick blood samples were taken. Temperatures of 33-34°C (thermoneutral) and 50°C (thermotherapy) indicate the temperature of the water pumped through water-perfused suit. BP: blood pressure; SkBF: skin blood flow; T : core temperature; HFM: high fat meal.
Blood triglyceride and blood glucose data. Both blood triglycerides and blood glucose increased above baseline in both high fat meal trials. HFM: high fat meal; HFM-TT: high fat meal plus thermotherapy. P < 0.0125 versus baseline within the same trial. Values are means ± SEM.
| Blood triglycerides (mg/dL) | Blood glucose (mg/dL) | |||
|---|---|---|---|---|
| Baseline | After high fat meal | Baseline | After high fat meal | |
| Control | 84 ± 9 | 83 ± 5 | ||
| HFM | 88 ± 6 | 178 ± 16 | 84 ± 3 | 105 ± 3 |
| HFM-TT | 91 ± 9 | 173 ± 14 | 82 ± 3 | 102 ± 4 |
Blood pressure and heart rate data. There were no differences in any of the blood pressure values between the three trials. HFM: high fat meal trial; HFM-TT: high fat meal plus thermotherapy trial. Values are means ± SEM. P < 0.05 versus control and HFM conditions.
| Systolic blood pressure (mmHg) | Diastolic blood pressure (mmHg) | Mean arterial blood pressure (mmHg) | Heart rate | |
|---|---|---|---|---|
| Control | 116 ± 5 | 76 ± 5 | 89 ± 5 | 61 ± 2 |
| HFM | 120 ± 5 | 77 ± 5 | 91 ± 5 | 68 ± 3 |
| HFM-TT | 118 ± 6 | 75 ± 4 | 90 ± 4 | 88 ± 3 |
Baseline %CVCmax data. Baseline values for the three experimental trials. Pre-HFM was defined as the three-minute period just prior to either the thermoneutral or TT; post-HFM was defined as the three-minute period immediately preceding the end of either the thermoneutral or TT; pre-local heating was defined as the three-minute period just prior to beginning the local heating protocol. HFM: high fat meal; HFM-TT: high fat meal plus mild heat stress trial. P < 0.05 versus same time point compared to HFM; # P < 0.05 versus pre-HFM and pre-local heating within the same trial. Values are means ± SEM.
| Control trial | HFM trial | HFM-TT trial | |
|---|---|---|---|
| Pre-HFM | 14 ± 2 | 18 ± 3 | |
| Post-HFM | 13 ± 2 | 32 ± 3 | |
| Pre-local heating | 17 ± 3 | 17 ± 3 | 21 ± 5 |
Figure 2Initial peak %CVCmax. Initial peak %CVCmax for the control, high fat meal (HFM), and high fat meal plus TT (HFM-TT) trials. There was no effect of the HFM on the initial peak compared to the control trial. Initial peak was augmented in the HFM-TT trial compared to the control and HFM trials. P < 0.05 versus control and HFM trials. Data are group mean ± SEM.
Figure 3Plateau %CVCmax. Plateau %CVCmax for the control, high fat meal (HFM), and high fat meal plus TT (HFM-TT) trials. Plateau in the HFM trial was attenuated compared to both the control and HFM-TT trials. There was no difference between the control and HFM-TT trials. P < 0.05 versus control and HFM-TT trials. Data are group mean ± SEM.
Linear regression for the correlation between %CVCmax and blood triglycerides and blood glucose for both the initial peak and plateau phase of cutaneous thermal hyperemia. HFM: high fat meal; HFM-TT: high fat meal + thermotherapy; TRG: blood triglycerides; GLU: blood glucose. ∗ indicates statistically significant Pearson correlation and standardized beta coefficient.
| Control | HFM | HFM-TT | ||||
|---|---|---|---|---|---|---|
| TRG | GLU | TRG | GLU | TRG | GLU | |
|
| ||||||
| Pearson correlation | 0.424 | 0.252 | 0.267 | −0.145 | −0.268 | −0.433 |
|
| 0.148 | 0.273 | 0.262 | 0.366 | 0.260 | 0.142 |
|
| ||||||
| Standardized | 0.434 | 0.269 | 0.305 | −0.203 | −0.424 | −0.552 |
|
| 0.313 | 0.518 | 0.509 | 0.657 | 0.309 | 0.201 |
|
| ||||||
|
| ||||||
| Pearson correlation | 0.542 | 0.162 | −0.827 | 0.108 | −0.739 | 0.540 |
|
| 0.082 | 0.351 | 0.006 | 0.399 | 0.018 | 0.083 |
|
| ||||||
| Standardized | 0.550 | 0.183 | −0.879 | 0.275 | −0.637 | 0.361 |
|
| 0.195 | 0.639 | 0.01 | 0.275 | 0.064 | 0.238 |